Insulin sensitisation in post-menarcheal girls with a history of low birthweight and precocious pubarche: effects of the addition of antiandrogen treatment and of the androgen receptor length on body composition and endocrine-metabolic parameters

ISRCTN ISRCTN08608368
DOI https://doi.org/10.1186/ISRCTN08608368
Secondary identifying numbers N/A
Submission date
07/09/2005
Registration date
05/10/2005
Last edited
11/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Lourdes Ibañez
Scientific

Hospital Sant Joan de Deu
Passeig de Sant Joan de Deu 2
Esplugues, Barcelona
08950
Spain

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesThe endocrine-metabolic effects of insulin sensitisation +/- antiandrogen therapy will be directly related to the length of CAG repeats of the androgen receptor gene.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedOvarian hyperandrogenism
InterventionInsulin sensitisation +/- antiandrogen treatment
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Insulin, antiandrogen
Primary outcome measure1. Development of clinical hyperandrogenism
2. Body composition
Secondary outcome measures1. Decrease of androgens
2. Improvement of insulin sensitivity
Overall study start date20/10/2003
Completion date20/10/2006

Eligibility

Participant type(s)Patient
Age groupChild
SexFemale
Target number of participants20
Key inclusion criteria1. Post-menarcheal state
2. A history of low birthweight and precocious pubarche
3. Subclinical ovarian hyperandrogenism
4. Hyperinsulinemia
Key exclusion criteria1. Clinical signs of androgen excess
2. Family or personal history of diabetes mellitus
3. Late-onset congenital adrenal hyperplasia
Date of first enrolment20/10/2003
Date of final enrolment20/10/2006

Locations

Countries of recruitment

  • Spain

Study participating centre

Hospital Sant Joan de Deu
Esplugues, Barcelona
08950
Spain

Sponsor information

Hospital Sant Joan de Deu (Spain)
Hospital/treatment centre

Passeig de Sant Joan de Deu, 2
Esplugues, Barcelona
08950
Spain

ROR logo "ROR" https://ror.org/001jx2139

Funders

Funder type

Hospital/treatment centre

Hospital Sant Joan de Deu (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2007 Yes No